Posted by Two Blokes
– Largest hypertension trial of an aldosterone synthase inhibitor to date demonstrated the efficacy of lorundr
Source: Two Blokes Trading
Posted by Two Blokes
On Holding (ONON -0.54%) is being hit by tariffs like everyone else, but the company's response is unique. Man
Source: Two Blokes Trading
Posted by Two Blokes
The resignation comes after the company's poor performance in the first quarter of 2025.
Source: Two Blokes Trading
Posted by Two Blokes
Vanguard is known for its low-cost ETFs, and for very good reasons. Decades ago, Vanguard pioneered the concep
Source: Two Blokes Trading
Posted by Two Blokes
NEW YORK, May 24, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a
Source: Two Blokes Trading
Posted by Two Blokes
The past few years have been difficult -- to say the least -- for Intel (INTC -2.34%). Competitors like Nvidia
Source: Two Blokes Trading
Posted by Two Blokes
Rocket Lab (RKLB -1.51%) is on a roll.
Source: Two Blokes Trading
Posted by Two Blokes
The stock market is anything but normal right now. Not even halfway through the year, the broader benchmark S&
Source: Two Blokes Trading
Posted by Two Blokes
BigBear.ai (BBAI -4.19%) is an innovative AI company with lucrative government contracts.
Source: Two Blokes Trading
Posted by Two Blokes
Nvidia CEO Jensen Huang on Saturday praised U.S. President Donald Trump's efforts to boost U.S. technology as
Source: Two Blokes Trading
Posted by Two Blokes
Moody's delivered strong Q1 results, but shares lagged after a guidance cut due to macro uncertainty and weake
Source: Two Blokes Trading
Posted by Two Blokes
In Q2 and Q3, most of Tesla's revenue growth is coming from things it's already executing. The global Model Y
Source: Two Blokes Trading